Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1879 1
1941 1
1943 1
1946 1
1948 1
1950 2
1951 1
1954 2
1955 3
1956 1
1957 3
1958 4
1959 4
1960 2
1961 2
1962 3
1963 10
1964 10
1965 13
1966 12
1967 7
1968 11
1969 13
1970 8
1971 8
1972 18
1973 13
1974 4
1975 3
1976 6
1977 9
1978 8
1979 10
1980 7
1981 15
1982 9
1983 11
1984 17
1985 16
1986 14
1987 17
1988 11
1989 14
1990 14
1991 21
1992 18
1993 27
1994 41
1995 25
1996 36
1997 28
1998 27
1999 16
2000 24
2001 31
2002 33
2003 35
2004 35
2005 33
2006 42
2007 45
2008 41
2009 44
2010 59
2011 62
2012 54
2013 61
2014 53
2015 57
2016 59
2017 57
2018 56
2019 81
2020 79
2021 83
2022 79
2023 87
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

1,747 results

Results by year

Filters applied: . Clear all
Page 1
The Biology of Sex and Sport.
Bassett AJ, Ahlmen A, Rosendorf JM, Romeo AA, Erickson BJ, Bishop ME. Bassett AJ, et al. Among authors: bishop me. JBJS Rev. 2020 Mar;8(3):e0140. doi: 10.2106/JBJS.RVW.19.00140. JBJS Rev. 2020. PMID: 32224635 Review.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT; JULIET Investigators. Schuster SJ, et al. Among authors: bishop mr. N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1. N Engl J Med. 2019. PMID: 30501490 Clinical Trial.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R. Shah BD, et al. Among authors: bishop mr. Lancet. 2021 Aug 7;398(10299):491-502. doi: 10.1016/S0140-6736(21)01222-8. Epub 2021 Jun 4. Lancet. 2021. PMID: 34097852 Clinical Trial.
Unraveling the Mechanisms of Manual Therapy: Modeling an Approach.
Bialosky JE, Beneciuk JM, Bishop MD, Coronado RA, Penza CW, Simon CB, George SZ. Bialosky JE, et al. Among authors: bishop md. J Orthop Sports Phys Ther. 2018 Jan;48(1):8-18. doi: 10.2519/jospt.2018.7476. Epub 2017 Oct 15. J Orthop Sports Phys Ther. 2018. PMID: 29034802
Mentorship in Medicine and Other Health Professions.
Henry-Noel N, Bishop M, Gwede CK, Petkova E, Szumacher E. Henry-Noel N, et al. Among authors: bishop m. J Cancer Educ. 2019 Aug;34(4):629-637. doi: 10.1007/s13187-018-1360-6. J Cancer Educ. 2019. PMID: 29691796 Review.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M, Han X, Tiwari R, Salles G, Maziarz RT. Schuster SJ, et al. Among authors: bishop mr. Lancet Oncol. 2021 Oct;22(10):1403-1415. doi: 10.1016/S1470-2045(21)00375-2. Epub 2021 Sep 10. Lancet Oncol. 2021. PMID: 34516954 Clinical Trial.
Editorial.
Bishop M. Bishop M. Brief Bioinform. 2023 May 19;24(3):bbad176. doi: 10.1093/bib/bbad176. Brief Bioinform. 2023. PMID: 37165976 No abstract available.
With Gratitude.
Bishop MC. Bishop MC. J Cancer Educ. 2023 Aug;38(4):1107-1108. doi: 10.1007/s13187-023-02328-2. J Cancer Educ. 2023. PMID: 37365372 No abstract available.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
Bishop MR, Dickinson M, Purtill D, Barba P, Santoro A, Hamad N, Kato K, Sureda A, Greil R, Thieblemont C, Morschhauser F, Janz M, Flinn I, Rabitsch W, Kwong YL, Kersten MJ, Minnema MC, Holte H, Chan EHL, Martinez-Lopez J, Müller AMS, Maziarz RT, McGuirk JP, Bachy E, Le Gouill S, Dreyling M, Harigae H, Bond D, Andreadis C, McSweeney P, Kharfan-Dabaja M, Newsome S, Degtyarev E, Awasthi R, Del Corral C, Andreola G, Masood A, Schuster SJ, Jäger U, Borchmann P, Westin JR. Bishop MR, et al. N Engl J Med. 2022 Feb 17;386(7):629-639. doi: 10.1056/NEJMoa2116596. Epub 2021 Dec 14. N Engl J Med. 2022. PMID: 34904798 Clinical Trial.
1,747 results